Skip to main content
Caplight Logo









Avisa Myko

Avisa Myko

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.avisamyko.com/

Last Round

Pre Seed

Aug 5, 2021

Total Funding Raised

$400,000

Company Overview

Avisa Myko is a biotechnology company that develops and manufactures affordable, water-soluble melanin using proprietary fermentation technology for applications in cosmetics, radiation protection, and bioelectronics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials, Advanced Materials

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Non-AI

Keywords

mycologybiotechnologymelaninprecision fermentationbio-based materialsfungal-derived productssustainable materialsbiomaterialsradiation shieldingbioelectronicssynthetic biologysynbiomaterial scienceR&D servicesbiotech supplier

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Avisa Myko Comparables

Compare Avisa Myko with similar companies based on industry and business-model similarity.

Avisa Myko comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ecovative
73%
Michroma
69%
Melazyme
65%

Avisa Myko Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedAug 5, 2021
Pre SeedAug 5, 2021
AcceleratorNov 1, 2019

Key People

Founding team and executive leadership

Ravi Adgulwar

Co-Founder and CEO

Founding Team

Avisa Myko Investors

Notable investors and investment history

Avisa Myko investors
InvestorRounds
Innovation Network for Advanced MaterialsPre Seed
Advisors.FundPre Seed
VII VenturesPre Seed
IndieBioAccelerator
SOSVAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 1, 2025

    Monthly visitors grew 393% MoM, from 193 to 951.

  • Aug 5, 2021

    $200K raised in Pre Seed round.

Avisa Myko Filings

Explore SEC and related filing metadata, where available.

Avisa Myko filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Avisa Myko's valuation, stock price, and market status.

Is Avisa Myko a public or private company?

Avisa Myko is a private company.

What is the current stock price of Avisa Myko?

Avisa Myko is a private company with no public stock price. No recent secondary market data is available.

How much is Avisa Myko worth (valuation)?

Valuation information for Avisa Myko is not publicly available.

Can I buy Avisa Myko stock?

Avisa Myko shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Avisa Myko's last funding round?

Avisa Myko's most recent funding round was Pre Seed on August 5, 2021.

Who are the main investors in Avisa Myko?

Key investors in Avisa Myko include SOSV.

Will Avisa Myko IPO soon?

No public IPO plans have been announced for Avisa Myko.

How can I track Avisa Myko secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Avisa Myko's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range6
Year Founded2019
Last FundingAug 5, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?